Status:

TERMINATED

Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)

Lead Sponsor:

McMaster University

Collaborating Sponsors:

Société des Produits Nestlé (SPN)

Conditions:

Crohn's Disease

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This study evaluates the effect of Exclusive Enteral Nutrition (EEN) in addition to different regimes of corticosteroid (CS) therapy (Prednisone) compared to CS alone in adults participants with activ...

Detailed Description

Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by diarrhea, abdominal pain and bleeding. There are several treatment options but the most-widely used for acute therapy are c...

Eligibility Criteria

Inclusion

  • Confirmed CD for at least 6 months
  • Clinically active disease (CDAI \>220 or Harvey-Bradshaw Index (HBI) \>6) or active by endoscopy.
  • Biochemical evidence of disease activity (CRP \>5 and/or fecal calprotectin \>250)

Exclusion

  • Currently using EEN
  • Condition that would preclude the use of EEN, such as Intestinal obstruction, perforation, toxic megacolon, massive gastrointestinal bleeding, abdominal abscess, or stricturing disease
  • Previous intestinal resection with a remnant bowel of less than 180 cm
  • Treatment with Prednisone in the last 30 days
  • New start or change in dose of azathioprine, 6-mercaptopurine, cyclosporine, other immunosuppressant or biologics in the last 90 days. Doses of these medications must also remain unchanged for the duration of the study
  • New start or change in dose of 5-aminosalicylic acid (ASA) in the last 30 days. 5ASA dose must remain unchanged for the duration of the study
  • Use of Antibiotics or Probiotics in the last 30 days
  • Pregnant or Lactating
  • Any serious illness which could interfere with study procedures or results

Key Trial Info

Start Date :

October 25 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2019

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT03833596

Start Date

October 25 2018

End Date

November 1 2019

Last Update

September 2 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McMaster University

Hamilton, on, Ontario, Canada, L8S 4K1